Literature DB >> 9158192

Adenocarcinoma of bladder.

N P Dandekar1, A V Dalal, H B Tongaonkar, M R Kamat.   

Abstract

Forty-eight patients with adenocarcinoma (21 urachal and 27 non-urachal) of the bladder were treated at the Tata Memorial Hospital between 1976 and 1992. The study group consisted of 32 men and 16 women. The urachal tumours were more common in younger patients (mean age: 49 years) than were non-urachal tumours (mean age: 58 years). The overall 5-year survival in this series was 37%. Stage and grade were powerful predictors of outcome. Patients with non-urachal tumours showed an overall survival rate of 29.9% compared with 45.7% in patients with urachal tumours (P= 0.14). Radical cystectomy was the most common treatment modality in patients with non-urachal tumours and yielded an overall 5-year survival of 35%. Patients with urachal tumours were treated with either partial cystectomy or radical cystectomy. The 5-year survival following partial cystectomy was 56.3% compared with 25.9% following a radical cystectomy and the difference between the two was not statistically significant (P = 0.76).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9158192     DOI: 10.1016/s0748-7983(97)80012-1

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  10 in total

1.  An unusual case of cancer of the urachal remnant following repair of bladder exstrophy.

Authors:  D M Fanning; M Sabah; P J Conlon; G J Mellotte; M G Donovan; D M Little
Journal:  Ir J Med Sci       Date:  2009-03-18       Impact factor: 1.568

2.  Primary adenocarcinoma of the urinary bladder: a single site analysis of 21 cases.

Authors:  Hu Zhang; Haowen Jiang; Zhong Wu; Zujun Fang; Jie Fan; Qiang Ding
Journal:  Int Urol Nephrol       Date:  2012-10-06       Impact factor: 2.370

3.  Primary adenocarcinoma of the renal pelvis, ureter and the urinary bladder: A case report and review of the literature.

Authors:  Xing Xiong; Linghua Jia; Jingen Wang
Journal:  Oncol Lett       Date:  2016-01-26       Impact factor: 2.967

4.  Alpha-methylacyl-coenzyme a racemase-expressing urachal adenocarcinoma of the abdominal wall.

Authors:  Yun-Sok Ha; Young-Won Kim; Byung-Dal Min; Ok-Jun Lee; Yong-June Kim; Seok-Joong Yun; Sang-Cheol Lee; Wun-Jae Kim
Journal:  Korean J Urol       Date:  2010-07-20

5.  Prognostic factors for urachal cancer: a bayesian model-averaging approach.

Authors:  In Kyong Kim; Joo Yong Lee; Jong Kyou Kwon; Jae Joon Park; Kang Su Cho; Won Sik Ham; Sung Joon Hong; Seung Choul Yang; Young Deuk Choi
Journal:  Korean J Urol       Date:  2014-09-05

Review 6.  Variant histology in bladder cancer: how it should change the management in non-muscle invasive and muscle invasive disease?

Authors:  Yvonne Klaile; Katrin Schlack; Martin Boegemann; Julie Steinestel; Andres Jan Schrader; Laura-Maria Krabbe
Journal:  Transl Androl Urol       Date:  2016-10

7.  Survival of contemporary patients with non-metastatic urachal vs. non-urachal adenocarcinoma of the urinary bladder.

Authors:  Stefano Luzzago; Carlotta Palumbo; Giuseppe Rosiello; Angela Pecoraro; Marina Deuker; Francesco Alessandro Mistretta; Zhe Tian; Gennaro Musi; Emanuele Montanari; Shahrokh F Shariat; Fred Saad; Alberto Briganti; Ottavio de Cobelli; Pierre I Karakiewicz
Journal:  World J Urol       Date:  2020-01-20       Impact factor: 4.226

8.  Clinical considerations, management and treatment of fever of unknown origin caused by urachal cyst: a case report.

Authors:  Vincenzo Bagnara; Salvatore Antoci; Salvatore Bonforte; Giovanna Privitera; Tonia Luca; Sergio Castorina
Journal:  J Med Case Rep       Date:  2014-03-25

Review 9.  Biomarkers in Urachal Cancer and Adenocarcinomas in the Bladder: A Comprehensive Review Supplemented by Own Data.

Authors:  Henning Reis; Ulrich Krafft; Christian Niedworok; Orsolya Módos; Thomas Herold; Mark Behrendt; Hikmat Al-Ahmadie; Boris Hadaschik; Peter Nyirady; Tibor Szarvas
Journal:  Dis Markers       Date:  2018-03-12       Impact factor: 3.434

10.  Retrospective analysis of palliative chemotherapy for the patients with bladder adenocarcinoma: Korean Cancer Study Group Genitourinary and Gynecology Cancer Committee.

Authors:  Moon Jin Kim; Young Sam Kim; Sung Yong Oh; Suee Lee; Young-Jin Choi; Young Mi Seol; Min Jae Park; Ki Hyang Kim; Lee Chun Park; Jung Hun Kang; In-Gyu Hwang; Soon Il Lee; Seung Taek Lim; Hyo Song Kim; Ho Yeong Lim; Sun Young Rha; Hyo-Jin Kim
Journal:  Korean J Intern Med       Date:  2016-04-06       Impact factor: 2.884

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.